These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 9494603

  • 1. Total and free PSA: a methodical and clinical evaluation of five assays.
    Reiter W, Stieber P, Schmeller N, Nagel D, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1997; 17(6D):4759-65. PubMed ID: 9494603
    [Abstract] [Full Text] [Related]

  • 2. The ratio of free to total prostate specific antigen: an advantageous addition in the differential diagnosis of benign hyperplasia and cancer of the prostate?
    Reiter W, Stieber P, Schmeller N, Nagel D, Jansen HM, Schambeck C, Fabricius PG, Pahl H, Mattes M, Constabel H, Fateh-Moghadam A.
    Anticancer Res; 1997; 17(4B):2987-91. PubMed ID: 9329582
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
    de La Taille A, Houlgatte A, Houdelette P, Berlizot P, Fournier R, Ricordel I.
    Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
    [Abstract] [Full Text] [Related]

  • 9. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
    Stephan C, Lein M, Jung K, Schnorr D, Loening SA.
    Cancer; 1997 Jan 01; 79(1):104-9. PubMed ID: 8988733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 01; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 13. [Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients)].
    de la Taille A, Houlgatte A, Houdelette P, Berlizot P, Ramirez J, Ricordel I.
    Prog Urol; 1997 Apr 01; 7(2):240-5. PubMed ID: 9264766
    [Abstract] [Full Text] [Related]

  • 14. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan.
    Egawa S, Soh S, Ohori M, Uchida T, Gohji K, Fujii A, Kuwao S, Koshiba K.
    Cancer; 1997 Jan 01; 79(1):90-8. PubMed ID: 8988731
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The percentage of free prostate specific antigen used in detecting prostate cancer].
    Yang L, Fang Z, Song J, Deng S.
    Zhonghua Wai Ke Za Zhi; 1999 Jan 01; 37(1):47-9. PubMed ID: 11829778
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. First clinical results with Enzymun-Test for free PSA.
    Gilson G, Lamy S, Humbel RL.
    Anticancer Res; 1997 Jan 01; 17(4B):2861-4. PubMed ID: 9329548
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of 3 investigational assays for the free form of prostate specific antigen.
    Nixon RG, Meyer GE, Blase AB, Gold MH, Brawer MK.
    J Urol; 1998 Aug 01; 160(2):420-5. PubMed ID: 9679890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.